You are viewing: Australia Single Cell Analysis Market analysis
Part of: Single Cell Analysis Market (Global)

The Australia Single Cell Analysis Market was valued at $37 Million in 2025 and projected to reach to $63.6 Million by 2030, representing a compound annual growth rate of 11.4%. Australia's single cell analysis market is positioned for sustained growth as the healthcare sector increasingly adopts advanced genomic technologies for precision medicine applications.

Australia Single Cell Analysis Market Trends and Insights

  • This 11.4% compound annual growth rate reflects Australia's increasing investment in precision medicine and genomic research capabilities.
  • Australia's healthcare sector is leveraging single cell analysis technologies to advance cancer research, immunology, and regenerative medicine applications. The Australian market benefits from strong government funding for biomedical research, world-class academic institutions, and growing adoption of single cell sequencing platforms across research centers and clinical laboratories.
  • Australia's position as a leader in Asia-Pacific life sciences innovation is driving demand for advanced analytical tools.
  • By 2030, Australia is expected to solidify its role as a regional hub for single cell analysis research and development. Australia's market growth is supported by collaborations between government agencies, universities, and private sector players focused on translating single cell discoveries into clinical applications.
  • The country's regulatory environment and investment in biotechnology infrastructure continue to position Australia as an attractive market for single cell analysis solutions..

Key Market Statistics

  • CAGR (2025-2030) 11.4% CAGR
  • Market Size, 2025 ~USD 37 Million
  • Forecast, 2030 ~USD 63.6 Million
  • Country Australia

Australia Single Cell Analysis Market Overview

Market Valuation Growth :

Australia's single cell analysis market is valued at $37.0 million in 2025, with projections reaching $63.6 million by 2030, representing a robust 11.4% CAGR driven by increased genomic research funding and precision medicine adoption.

Precision Medicine Investment :

Australian healthcare institutions are significantly investing in single cell analysis technologies to advance personalized treatment approaches, particularly in oncology and immunotherapy research, positioning the country as a regional innovation hub.

Research Infrastructure Expansion :

Major Australian research institutions and biotech companies are expanding their single cell analysis capabilities, supported by government initiatives and private sector investment in genomic sequencing infrastructure and analytical platforms.

Cancer and Immunology Focus :

Australian researchers are leveraging single cell analysis to accelerate cancer research and immunological studies, with applications in tumor microenvironment characterization and immune cell profiling driving market demand.

Australia Single Cell Analysis Market Dynamics

  • The 11.4% CAGR reflects growing investment in research infrastructure, particularly within academic institutions and biotech companies focused on cancer research and immunotherapy development.
  • Government support for genomic medicine initiatives and collaboration between public and private research entities are accelerating technology adoption across the country. The forecast expansion to $63.6 million by 2030 underscores Australia's commitment to becoming a leader in precision medicine within the Asia-Pacific region.
  • Increasing demand for personalized treatment approaches, coupled with declining sequencing costs and improved analytical capabilities, will drive market penetration across clinical and research settings.
  • Strategic partnerships with international biotech firms and continued investment in skilled workforce development will further strengthen Australia's competitive position in single cell analysis technologies..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • Australia's single cell analysis market is valued at $37.0 million in 2025 and is forecast to reach $63.6 million by 2030, representing an 11.4% CAGR.
      • Australia's strong government funding for biomedical research and world-class academic institutions are primary drivers of market expansion.
      • Single cell analysis adoption in Australia is accelerating across cancer research, immunology, and regenerative medicine applications.
      • Australia's regulatory environment and biotechnology infrastructure position it as a key Asia-Pacific hub for single cell analysis innovation.

      Single Cell Analysis Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment ACADEMIC & RESEARCH LABORATORIES (End User)
      Forecast Period 2025–2030
      Growth Rate CAGR of 14.7% from 2025 to 2030
      Largest Segment CONSUMABLES (Product)
      Market Size Base Year (Billions) ~USD 3.81 (2025)
      Revenue Forecast (Billions) ~USD 7.56 (2030)
      Segments Covered Application, Type, Cell Type, End User, Product

      Australia Single Cell Analysis Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Application

      • Medical Applications
      • Research Applications

      By Type

      • Assay Kits
      • Beads
      • Cancer Research
      • Circulating Tumor Cells
      • Immunology Research
      • In Vitro Fertilization
      • Microplates
      • Neurology Research
      • Non-Invasive Prenatal Diagnosis
      • Other Consumables
      • Other Research Applications
      • Reagents
      • Stem Cell Research

      By Cell Type

      • Animal Cells
      • Human Cells
      • Microbial Cells

      By End User

      • Academic & Research Laboratories
      • Biotechnology & Pharmaceutical Companies
      • Cell Banks & Ivf Centers
      • Hospitals & Diagnostic Laboratories

      By Product

      • Consumables
      • Instruments

      Target Audience

      • Biotech and Diagnostics Companies : Companies developing or commercializing single cell analysis platforms need Australia-specific market data to assess market size, growth potential, and competitive dynamics for product launches and expansion strategies in the region.
      • Research Institutions and Universities : Australian academic and research institutions require market intelligence to justify funding requests, benchmark their capabilities against peers, and identify collaboration opportunities in the growing single cell analysis ecosystem.
      • Healthcare Investment Firms : Venture capital and private equity investors focused on Australian biotech need detailed market analysis to evaluate investment opportunities, assess portfolio company growth potential, and identify emerging players in the single cell analysis space.
      • Government and Policy Makers : Australian health department officials and policy makers use market data to inform genomic medicine strategies, allocate research funding, and develop regulatory frameworks supporting precision medicine adoption and innovation.
      • Clinical Laboratory and Hospital Networks : Australian healthcare providers and diagnostic laboratories need market insights to evaluate single cell analysis technology adoption, understand implementation costs, and plan integration into clinical workflows and research programs.

      Key Companies in the Australia Single Cell Analysis Market

      CompanyHQOwnershipStrongest segments
      PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing and packaging),Pharmaceutical development services,Drug substance services (API and biologics),
      ABCAM PLCUnited KingdomPrivate CompanyPrimary antibodies,Secondary and conjugated antibodies,Immunoassays (singleplex) and kits,
      BECKMAN COULTERUnited StatesPrivate CompanyClinical diagnostics (chemistry, hematology, immunoassay, urinalysis, blood banking, hemostasis, integrated systems),Life science research and discovery (flow cytometry, genomic and protein analysis, liquid handling, research automation),Industrial and particle characterization (coulter counters, particle size, zeta potential, electrochemistry),
      DECODE GENETICSIcelandPrivate CompanyInternal genomics support for Amgen R&D,External research collaborations and consortia,Genome sequencing and analytical services,
      BDUnited StatesPublic CompanyMedical Essentials (syringes, needles, IV catheters, sharps, basic disposables),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems and related services),
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing, single-use, media, filtration, aseptic fill-finish),Life Sciences (instruments, genomics, proteomics, imaging, lab automation),Diagnostics (clinical instruments, consumables, software, services),
      10X GENOMICSUnited StatesPublic CompanyChromium instruments,Chromium consumables & QuantumScale kits,Visium spatial platform (instruments, slides, reagents),
      MERCK KGAAGermanyPublic CompanyLife Science (tools, consumables, bioprocessing, CDMO),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, gases, equipment),
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      QIAGENNetherlandsPublic CompanySample technology consumables and instruments,PCR and digital PCR (research and clinical),Molecular diagnostics assays (TB, oncology, SRH, transplant, viral load),
      ILLUMINA, INC.United StatesPublic CompanySequencing instruments,Sequencing consumables (reagents, flow cells, library prep),Array-based instruments and consumables,
      BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Instruments and Systems,Life Science Reagents and Consumables,
      DIASORIN S.P.A.ItalyPublic CompanyLIAISON XL / LIAISON XS immunodiagnostics,Molecular diagnostics (Simplexa, LIAISON PLEX assays),xMAP technology and other IVD solutions,
      STANDARD BIOTOOLSUnited StatesPublic CompanyProteomics platforms and consumables (SomaScan, CyTOF, Hyperion),Genomics platforms and consumables (Biomark X9 and legacy genomics),Services, software, and other,
      SARTORIUS AGGermanyPublic CompanyBioprocess solutions (bioreactors, filtration, chromatography, fluid management),Lab products and services (weighing, pipetting, filtration, water systems, microbiological testing),Analytical solutions (BLI, cytometry, live-cell imaging, SPR, PAT and data analytics),
      CORNING INCORPORATEDUnited StatesPublic CompanyOptical communications (fiber, cable, connectivity, hardware),Display glass substrates (LCD and OLED),Specialty materials and mobile consumer electronics glass,
      CYTEK BIOSCIENCESUnited StatesPublic CompanyAurora / Aurora Evo / Aurora CS spectral systems,Northern Lights and mid-range flow cytometers,Amnis imaging flow cytometers,

      PATHEON INC

      Patheon Inc is a Netherlands-based private company with 9,100 employees operating in the life sciences sector.

      ABCAM PLC

      Abcam PLC is a United Kingdom-based private company founded in 1998 with 1,760 employees specializing in life science research products.

      BECKMAN COULTER

      Beckman Coulter is a United States-based private company founded in 1935 with 11,900 employees manufacturing laboratory instruments and diagnostics.

      DECODE GENETICS

      Decode Genetics is an Iceland-based private company founded in 1996 with 331 employees focused on genetic research and analysis.

      BD

      BD is a United States-based public company founded in 1897 with 72,000 employees manufacturing medical devices, diagnostics, and life science tools.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees providing laboratory equipment, reagents, and services.

      DANAHER CORPORATION

      Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees operating diversified businesses including life sciences and diagnostics.

      10X GENOMICS

      10X Genomics is a United States-based public company founded in 2012 with 1,178 employees developing single-cell and spatial genomics solutions.

      MERCK KGAA

      Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees operating in pharmaceuticals, life sciences, and performance materials.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees manufacturing analytical instruments and life science tools.

      QIAGEN

      QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees providing molecular diagnostics and sample preparation solutions.

      ILLUMINA, INC.

      Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees developing DNA sequencing and genetic analysis technologies.

      BIO-RAD LABORATORIES, INC.

      Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees manufacturing life science research and clinical diagnostics products.

      DIASORIN S.P.A.

      DiaSorin S.p.A. is an Italy-based public company founded in 1968 with 3,242 employees specializing in in vitro diagnostics and immunoassay systems.

      STANDARD BIOTOOLS

      Standard Biotools is a United States-based public company founded in 1999 with 387 employees developing microfluidics and single-cell analysis platforms.

      SARTORIUS AG

      Sartorius AG is a Germany-based public company founded in 1870 with 14,242 employees providing laboratory and bioprocess equipment and services.

      CORNING INCORPORATED

      Corning Incorporated is a United States-based public company founded in 1851 with 67,200 employees manufacturing specialty glass, ceramics, and life science products.

      CYTEK BIOSCIENCES

      Cytek Biosciences is a United States-based public company founded in 1992 with 678 employees developing flow cytometry and cell analysis technologies.

      Reasons to Buy this Report

      • Market-Specific Growth Projections : Access detailed forecasts for Australia's single cell analysis market through 2030, enabling strategic planning and investment decisions based on localized growth trajectories and CAGR analysis specific to the Australian healthcare landscape.
      • Competitive Landscape Intelligence : Understand the competitive positioning of Australian biotech companies, research institutions, and international players operating in the single cell analysis space, identifying market opportunities and partnership potential within Australia.
      • Regulatory and Funding Environment : Gain insights into Australian government initiatives, research funding mechanisms, and regulatory frameworks supporting single cell analysis adoption, critical for navigating market entry and expansion strategies in the region.
      • Application-Specific Demand Analysis : Identify high-growth application areas within Australia including cancer research, immunology, and precision medicine, with detailed market segmentation to target the most promising clinical and research segments.
      • Regional Market Differentiation : Leverage Australia-specific data to differentiate from global market reports, understanding unique characteristics of the Australian healthcare system, research priorities, and technology adoption patterns distinct from other regions.

      Frequently asked questions

      What is the current market size of single cell analysis in Australia?

      Australia's single cell analysis market is valued at $37.0 million in 2025 and is projected to grow to $63.6 million by 2030.

      What is the growth rate of Australia's single cell analysis market?

      Australia's single cell analysis market is growing at a compound annual growth rate (CAGR) of 11.4% from 2025 to 2030.

      What are the primary applications driving Australia's single cell analysis market?

      Australia's market is driven by applications in cancer research, immunology, regenerative medicine, and precision medicine, supported by strong academic and research institutions.

      Which factors are supporting market growth in Australia?

      Australia's market growth is supported by government funding for biomedical research, world-class academic institutions, regulatory support, and increasing adoption of sequencing platforms.

      How does Australia's market compare to the broader Asia-Pacific region?

      Australia's 11.4% CAGR positions it as a significant contributor to Asia-Pacific single cell analysis growth, with strong institutional capabilities and research infrastructure.

      RESEARCH METHODOLOGY

      This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-cell analysis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

      Secondary Research

      Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-cell analysis market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), International Clinical Cytometry Society (ICCS), International Society for Advancement of Cytometry (ISAC), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), and Society for Laboratory Automation and Screening (SLAS), Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

      Primary Research

      Extensive primary research was conducted after acquiring basic knowledge about the global single-cell analysis market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, cell banks, and IVF centers, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across five major regions, including the Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

      The following is a breakdown of the primary respondents:

      Single Cell Analysis Market
 Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell analysis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      Bottom-up Approach

      • The key players in the industry and market have been identified through extensive secondary research
      • The revenues generated from the single-cell analysis business of leading players have been determined through primary and secondary research
      • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

      Top-down Approach

      • After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

      Single Cell Analysis Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Single-cell analysis is a method for examining individual cells across various parameters, particularly beneficial when dealing with diverse cell populations. This approach focuses on studying a single cell isolated from tissues in a multicellular organism. Technologies including flow cytometry and microfluidics are used for single-cell analysis purpose. Such analysis facilitates the exploration of variations between cells within a population. Currently, single-cell analysis finds extensive applications in cancer research, immunology, stem cell research, and neurobiology.

      Stakeholders

      • Single-cell analysis product manufacturers, vendors, and distributors
      • Academic and research laboratories
      • Pharmaceutical and biopharmaceutical companies
      • Venture capitalists and investors
      • Government organizations
      • Private research firms
      • Cell Banks & IVF centers
      • Hospitals & diagnostic centers

      Report Objectives

      • To define, describe, segment, and forecast the single-cell analysis market by product, cell type, technique, application, end user, and region
      • To provide detailed information about the major factors influencing market growth, such as drivers, restraints, opportunities, and challenges
      • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall single-cell analysis market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the market segments concerning six main regions: North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa
      • To strategically profile the key players in the global single-cell analysis market and comprehensively analyze their core competencies2 and market rankings
      • To track and analyze competitive developments in the single-cell analysis market, such as product launches, acquisitions, collaborations, expansions, and partnerships
      • To benchmark players within the single-cell analysis market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business excellence and product strategy

      Available Customizations

      With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

      Portfolio Assessment

      • Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies.
      Company Information
      • Detailed analysis and profiling of additional market players (up to five).
      Geographical Analysis
      • A further breakdown of the Rest of Europe  single-cell analysis market into countries
      • A further breakdown of the Rest of Asia Pacific single-cell analysis market into countries
      • A further breakdown of the Rest of Latin American single-cell analysis market into countries
      • A further breakdown of the Rest of Middle East single-cell analysis market into countries

      Get the Full Single Cell Analysis Market Report

      Full forecast, segment splits, and company analysis for all Single Cell Analysis Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status